The COVID-19 vaccine against coronavirus infection developed in Thailand will be ready for mass use in the fourth quarter of 2021, said the director of the National Vaccination Institute of the country, Dr. Nakhon Premi, at a press briefing at the Thai Ministry of Health.
“The vaccine will be ready for mass use only in the fourth quarter of 2021,” he said.
“Animal vaccine trials have already shown excellent results, but for mass use it is necessary to completely complete the test cycle, including human volunteers, and then produce enough doses to vaccinate at least one third of the Thai population, that is, at least 23 million doses “, – explained the head of the institute.
He said that on Saturday, scientists at the University of Chulalongkorn working as part of the National Institute of Vaccination’s overall vaccine development program began comprehensive testing of the vaccine on monkeys.
“These tests will take from one to one and a half months and will probably end by the beginning of July. Then the stage will be followed by the production of the first batch of vaccine doses for testing on human volunteers. Production is a laborious and lengthy process, even if it is a limited number of doses. Testing will end in October – November of this year, and only then it will be possible to begin mass production, “Premsey said.
He explained that the duration of the vaccine testing process, both in animals and in humans, is explained by the need to carefully check and fully verify the two main characteristics of the vaccine: its effectiveness and safety for humans.
The head of the Thai National Vaccination Institute also said that the Thai COVID-19 vaccine program, which is being implemented through collaboration between the Ministry of Health and the Ministry of Higher Education, Science and Innovation of Thailand, is being implemented with the involvement of manufacturing partners from the private sector and foreign research partners in the field of vaccines.
Thus, the University of Pennsylvania in the USA checks and confirms the results of testing conducted in Thailand, the first batches of vaccine for human testing are produced by private companies in the USA and Canada, and BioNet Asia will carry out mass production of the vaccine in Thailand.
“In addition to scientists from the University of Chulalongkorn, scientists from Prince Mahidol University and employees of two research organizations – the National Vaccination Institute of the Ministry of Health and the Institute for Innovation Research and Development of the Ministry of Higher Education, Science and Innovation, also participate in the program,” he said.
“Thailand is one of the eleven countries in the world where the process of creating a vaccine against coronavirus infection COVID-19 has advanced quite far. China, the USA, Great Britain, Germany and Australia are leading among these countries, they have already begun testing on people,” Premysi said adding that eleven countries are developing more than a hundred different types of coronavirus vaccines.
“All work in all countries is carried out in constant contact with the World Health Organization (WHO). Ultimately, the most successful of these vaccines will be accepted for mass production in these countries and will be delivered to other countries of the world that do not have the ability to create vaccines.” , – he said.
“It is impossible to cover all the world’s population with one vaccine at once, production will take years, and therefore there is a need to create vaccines by many states at the same time,” he added.
The vaccine developed in Thailand is an RNA vaccine whose action is based on enhancing the body’s production of antibodies to the coronavirus, explained the head of the Thai National Vaccination Institute.